PTPRD

Chr 9

protein tyrosine phosphatase receptor type D

Also known as: HPTP, HPTPD, HPTPDELTA, PTPD, R-PTP-delta, RPTPDELTA

This receptor-type protein tyrosine phosphatase regulates synaptic differentiation and neuronal axon guidance through trans-synaptic interactions. Mutations cause neurodevelopmental disorders with intellectual disability and restless legs syndrome, inherited in an autosomal dominant pattern. The gene is extremely constrained against loss-of-function variants, indicating that complete loss of protein function is likely incompatible with normal development.

OMIMResearchSummary from RefSeq, UniProt
LOEUF 0.11
Clinical SummaryPTPRD
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.11LOEUF
pLI 1.000
Z-score 8.52
OE 0.05 (0.030.11)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint
0.27Z-score
OE missense 0.98 (0.931.03)
1058 obs / 1083.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.05 (0.030.11)
00.351.4
Missense OE0.98 (0.931.03)
00.61.4
Synonymous OE1.36
01.21.6
LoF obs/exp: 5 / 94.2Missense obs/exp: 1058 / 1083.3Syn Z: -5.58

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PTPRD · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →